Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Optimal Allocation Mechanism for Scarce Public Goods: A Cross-Country Analysis and Key Lessons from COVID-19 Vaccines

Version 1 : Received: 17 May 2023 / Approved: 18 May 2023 / Online: 18 May 2023 (05:36:22 CEST)

How to cite: Hoang, V. Optimal Allocation Mechanism for Scarce Public Goods: A Cross-Country Analysis and Key Lessons from COVID-19 Vaccines. Preprints 2023, 2023051279. https://doi.org/10.20944/preprints202305.1279.v1 Hoang, V. Optimal Allocation Mechanism for Scarce Public Goods: A Cross-Country Analysis and Key Lessons from COVID-19 Vaccines. Preprints 2023, 2023051279. https://doi.org/10.20944/preprints202305.1279.v1

Abstract

How to optimally allocate COVID-19 vaccines and scarce public goods is a crucial and sensitive question to scholars, policy-makers, and practitioners. The ethical dimensions and principles of vaccine allocation between groups are widely agreed upon, whereas the ethical dimensions and principles of vaccine distribution between countries at the peak of the COVID-19 pandemic are highly controversial. This article aims to investigate how vaccines were globally allocated across countries and propose an optimal allocation mechanism for vaccines and scarce public goods. The results show that, to a certain extent, the global allocation of COVID-19 vaccines was fair and effective. Countries with more cases and deaths obtained more vaccines and vaccinations. Wealthier countries might receive more vaccinations but also suffer more severe consequences of COVID-19. Though COVAX could miss its initial vaccine delivery targets, the facility should be considered successful in its core goals and plays a critical role in controlling the pandemic. The study proposes a fair and effective mechanism of vaccine allocation that combines the roles of markets and interventions of international organizations and national governments with three degrees: emergency, priority, and market.

Keywords

Optimal Allocation; Vaccine; Scarce Public Goods; COVID-19; Pandemic; COVAX

Subject

Public Health and Healthcare, Health Policy and Services

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.